The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|10|1|55-67

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.1, 2009-01, pp. : 55-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p38 MAPK: A Potential Target of Chronic Pain

By  

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-01 ,pp. : 4405-4418

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Design of Novel Potential p38 MAPK Inhibitors with Drug-like Properties Using Pharmacophore and Similarity-based Virtual Screening Procedures

By  

Current Bioactive Compounds, Vol. 9, Iss. 1, 2013-03 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of the joint-protective effects of p38 MAPK inhibitors in rodent arthritis

By Mbalaviele Gabriel   Monahan Joseph B  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 2, 2008-02 ,pp. : 163-172

Informa Healthcare

Access to resources Recommend Favorite

p38 MAPK inhibitors: a patent review (2012 – 2013)

By Bühler Stefanie   Laufer Stefan A  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 535-554

Informa Healthcare

Access to resources Recommend Favorite

The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 823-833

Bentham Science Publishers

Access to resources Recommend Favorite